SOURCE: Hansen Medical, Inc.

Hansen Medical, Inc.

September 13, 2011 16:01 ET

Hansen Medical to Present at the UBS Global Life Sciences Conference

MOUNTAIN VIEW, CA--(Marketwire - Sep 13, 2011) - Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in flexible catheter robotics and the developer of robotic technology for accurate 3D control of catheter movement, announced today that President and CEO Bruce Barclay is scheduled to present at the UBS Global Life Sciences Conference. The conference is being held September 19-21, 2011 at the Grand Hyatt New York in New York City. Hansen Medical is scheduled to present on Wednesday, September 21, 2011 at 9:00 a.m. Eastern Time.

Hansen Medical will provide a live webcast of the audio presentation. Interested parties may access the live webcast by visiting the investor relations section of Hansen Medical's web site at A replay of the webcast will be available at the site after the presentation.

About Hansen Medical, Inc.
Hansen Medical, Inc., based in Mountain View, California, develops products and technology using robotics for the accurate positioning, manipulation and control of catheters and catheter-based technologies. The company's Sensei® X Robotic Catheter System and Artisan Control Catheter were cleared by the U.S. Food and Drug Administration for manipulation and control of certain mapping catheters in electrophysiology (EP) procedures. This robotic catheter system is compatible with fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram data. In the United States, the Sensei System is not approved for use in guiding ablation procedures; this use remains experimental. The U.S. product labeling therefore provides that the safety and effectiveness of the Sensei X System and Artisan catheter for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including atrial fibrillation (AF), have not been established. In the European Union, the Sensei X System and Artisan catheter are cleared for use during EP procedures, such as guiding catheters in the treatment of AF, and the Lynx® Robotic Ablation Catheter is cleared for the treatment of AF. The company's Magellan Robotic System, which is intended to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices, has undergone conformity assessment and CE marking and is commercially available in the European Union. The NorthStar Robotic Catheter and related accessories designed for use with the Magellan Robotic System are not yet CE marked. In the U.S., the Magellan Robotic System, the NorthStar Robotic Catheter and accessories are the subject of a current filing with the FDA and are not commercially available. Additional information can be found at

Hansen Medical, Heart Design, Hansen Medical & Heart Design, Sensei, Artisan and Lynx are registered trademarks, and Magellan and NorthStar are trademarks of Hansen Medical, Inc. in the United States and other countries.

Contact Information

  • Investor Contacts:
    Peter J. Mariani
    Chief Financial Officer
    Hansen Medical

    Matt Clawson
    Allen & Caron Inc
    Email Contact